Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Evaluating Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation With Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery

NCT05437757 is registered in ClinicalTrials.gov with BellaSeno Pty Ltd as lead sponsor.

NCT NCT05437757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05437757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Evaluating Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation With Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery
Lead sponsor
BellaSeno Pty Ltd
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2022
Completion date
December 10, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast implant revision, congenital breast defect correction